NASDAQ:CRSM

Finance·Investment·NASDAQ:CRSM·News·Stock Market

Carlsmed Stock Faces A Crucial Week After Friday’s Drop

Carlsmed shares closed Friday at $11.42, down 3.3% on the day and 24% below their July 2025 IPO price. The company reported Q1 revenue of $16.1 million, up 58% year over year, but net loss widened to $8.7 million. Shareholders are set to vote on directors and auditor at the June 3 annual meeting. Management will meet investors at three healthcare conferences in June.

June 1, 2026

Wise Shares Fall Amid Belgian Money Laundering Probe
June 1, 2026, 11:29 AM EDT. Wise, the UK-based international money transfer firm valued at over £8bn, is under investigation by Belgian prosecutors over money laundering concerns. The probe centers on alleged use of Wise accounts for laundering proceeds from fraud, corruption, and drug trafficking, involving around €500m in transactions. Wise is cooperating with authorities and emphasizes ongoing efforts to prevent financial crime through customer verification and transaction monitoring. Following confirmation of the investigation, Wise shares dropped more than 10%. The company, which shifted its primary listing to the US in 2024, had its co-founder fined £350,000 earlier this year for regulatory violations. This investigation highlights regulatory scrutiny on fintechs amid rising concerns over financial crime compliance.